Xiaohua C. Ban
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Multiparametric MRI-based radiomics and deep learning for differentiating uterine serous carcinoma from endometrioid carcinoma: a multicenter retrospective study.
Journal: Frontiers in oncology
Published: June 27, 2025
Preoperative prediction of lymph node status in oral squamous cell carcinoma: value of quantitative dual-energy CT parameters.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: March 18, 2025
MRI-based multimodal AI model enables prediction of recurrence risk and adjuvant therapy in breast cancer.
Journal: Pharmacological research
Published: March 02, 2025
Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation study.
Journal: Neuro-oncology
Published: July 11, 2024
Whole-tumor histogram analysis of multiple non-Gaussian diffusion models at high b values for assessing cervical cancer.
Journal: Abdominal radiology (New York)
Published: May 05, 2024
Achieving flexible fairness metrics in federated medical imaging.
Journal: Nature communications
Published: April 18, 2024
CT and MRI features of sarcomatoid urothelial carcinoma of the bladder and its differential diagnosis with conventional urothelial carcinoma.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: January 15, 2024
Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings.
Journal: Abdominal radiology (New York)
Published: December 04, 2022
False-negative and false-positive outcomes of computer-aided detection on brain metastasis: Secondary analysis of a multicenter, multireader study.
Journal: Neuro-oncology
Published: August 09, 2022
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer.
Journal: Journal for immunotherapy of cancer
Published: May 09, 2022
Last Updated: 09/26/2026